Skip to content
AnalystLens

Rocket Lab 8-K Report, Financial Results (Feb 27, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed February 27, 2025
Period End
February 27, 2025
Security
RKLB
In the record · 2020–202610-K810-Q188-K88

RKLB filed 8 annual reports (10-K), 18 quarterly reports (10-Q) and 88 current reports (8-K) between 2020 and 2026.

  1. Restatement8-K · May ’21May ’21
  2. Leadership change8-K · Sep ’22Sep ’22
  3. Material agreement8-K · Jan ’24Jan ’24
  4. Material agreement8-K · Jun ’26Jun ’26

01—Abstract

Summary

Summary of the 8-K filed February 27, 2025. Cited figures are marked; the original filing is the authoritative source.

Rocket Lab reported record full-year 2024 revenue of $436.2 milliona, up 78% from $244.6 million in 2023, and record fourth-quarter revenue of $132.4 million, up 121% year over year from $60.0 million.

Growth was driven by both segments: service revenue rose to $48.4 millionb in Q4 from $12.1 million, and product revenue rose to $84.0 million from $47.9 million. Profitability improved but remains negative. Q4 GAAP gross margin was about 27.8% (non-GAAP 34.0%), and GAAP operating loss narrowed to $51.5 million from $47.9 million, though it widened slightly year over year.

Full-year net loss was $190.2 millionc, or $0.38 per share, and Adjusted EBITDA loss improved to $96.9 million from $90.9 million. The balance sheet shows roughly $480 million in cash and marketable securities at year-end, including $271.0 million in cash, $147.9 million in current marketable securities and $60.7 million in non-current marketable securities. Against this, the company carries $345.4 million in net convertible senior notes issued in 2024.

Operating cash burn was $48.9 milliond for the year, and capital expenditures were $67.1 million. Management guided Q1 2025 revenue to $117 million to $123 million, which implies a sequential decline from Q4, with Adjusted EBITDA loss of $33 million to $35 million. Management also highlighted more than $450 million in new contracts, 16 Electron launches in 2024, and a planned second-half 2025 debut of the Neutron rocket.

For investors, the key question is whether revenue momentum and contract backlog can translate into margin expansion and sustained cash generation as the company scales. The Q1 guidance decline, continued operating losses and the Neutron debut timing are the main near-term watch items. This filing is furnished under Item 2.02 and is not deemed filed for Section 18 liability purposes.

02—Key points

Key Highlights

  1. Record FY2024 revenue of $436.2M, up 78% YoY; record Q4 revenue of $132.4M, up 121% YoY
  2. Q4 2024 GAAP gross margin of about 27.8% vs. non-GAAP gross margin of 34.0%, with GAAP gross profit of $36.8M
  3. FY2024 net loss of $190.2M ($0.38 per share), slightly wider than the $182.6M loss in 2023; Adjusted EBITDA loss improved to $96.9M from $90.9M in 2023 (per the non-GAAP reconciliation, a deterioration), so the comparison should be read carefully
  4. Year-end liquidity of roughly $480M in cash and marketable securities, against $345.4M in net convertible senior notes
  5. Q1 2025 guidance: revenue of $117M to $123M, a sequential decline from Q4, with Adjusted EBITDA loss of $33M to $35M
  6. Operating cash flow of -$48.9M for FY2024, a significant improvement from -$98.9M in 2023
  7. Over $450M in newly secured launch and space systems contracts; 16 Electron launches in 2024 (up 60%); Neutron debut targeted for 2H 2025

03—Questions

Frequently Asked Questions

  1. How strong was Rocket Lab's revenue growth in 2024?

    Full-year 2024 revenue was a record $436.2 million, up about 78% from $244.6 million in 2023. Q4 2024 revenue of $132.4 million was up about 121% from $60.0 million in Q4 2023. Service revenue grew sharply in Q4, from $12.1 million to $48.4 million, and product revenue rose from $47.9 million to $84.0 million.

  2. Is Rocket Lab approaching profitability?

    Not yet. The company reported a full-year 2024 GAAP operating loss of $189.8 million and a net loss of $190.2 million. The Q4 GAAP operating loss was $51.5 million, while the non-GAAP operating loss was $29.5 million. Adjusted EBITDA for 2024 was a loss of $96.9 million. Gross margin is improving but remains modest, at about 26.6% GAAP for the full year.

  3. What does the Q1 2025 guidance signal?

    Q1 2025 revenue guidance of $117 million to $123 million is below the Q4 2024 level of $132.4 million, which suggests lumpiness in revenue timing. Guidance also points to a GAAP gross margin of 25% to 27%, and an Adjusted EBITDA loss of $33 million to $35 million, indicating continued losses in the near term.

  4. How is Rocket Lab funding its operations and capital needs?

    At year-end 2024, the company held $271.0 million in cash and about $208.6 million in marketable securities. It issued $355 million in convertible senior notes in 2024, which are recorded at $345.4 million net of issuance costs, and it has about $56.1 million in borrowings. Capital expenditures were $67.1 million in 2024. Investors should monitor the cash burn rate against the Neutron development timeline and the notes' maturity.

  5. What are the key catalysts and risks to watch?

    Key catalysts include the planned second-half 2025 debut of the Neutron medium-lift rocket, execution on more than $450 million in new contracts, the Flatellite constellation platform, and the 20-plus Electron and HASTE launches planned for 2025. Risks include launch execution, the timing and cost of Neutron development, margin pressure, and ongoing operating losses. Note that this 8-K furnishes the earnings release, and the company's Form 10-K contains the full risk factor disclosures.

04—Continue

← View all 8-K filings